Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS Signaling
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Cell Systems
- Vol. 7 (2) , 161-179.e14
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Institutes of Health
- U.S. Department of Energy
- Science Foundation Ireland (14/IA/2395)
- Horizon 2020 Framework Programme (731032, 686098, 750688)
- National Institute of General Medical Sciences (R01GM111510)
This publication has 120 references indexed in Scilit:
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionNature, 2012
- Identification of a Novel Family of BRAFV600E InhibitorsJournal of Medicinal Chemistry, 2012
- Rapid Phospho-Turnover by Receptor Tyrosine Kinases Impacts Downstream Signaling and Drug BindingMolecular Cell, 2011
- Many Local Motions Cooperate to Produce the Adenylate Kinase Conformational TransitionJournal of Molecular Biology, 2010
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAFNature, 2010
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAFCell, 2010
- Four‐dimensional dynamics of MAPK information‐processing systemsWIREs Mechanisms of Disease, 2009
- Raf kinases: Function, regulation and role in human cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Extending the treatment of backbone energetics in protein force fields: Limitations of gas‐phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulationsJournal of Computational Chemistry, 2004
- All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of ProteinsThe Journal of Physical Chemistry B, 1998